Close Menu
December 02, 2019
Sponsored by

Powering Precision Medicine at Apollo Genetics

Case Study

Join or Log in for Access

This content is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Apollo Genetics, located in Baton Rouge, Louisiana, performs next-generation sequencing (NGS) diagnostics for cancer and pharmacogenetics. The CLIA-certified, CAP-accredited lab performs this testing for reference labs, physicians and directly to individuals. In 2019, Apollo acquired MedCompGx, also a Louisiana-based provider of NGS testing for cancer and pharmacogenetics. Today, the combined organization continues to deliver high-quality technology-driven services.

Sponsored by

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

Politico reports President Donald Trump has signed the $2 trillion coronavirus relief package.

A new analysis finds that peer review improves the quality of preprints just a little bit, according to ScienceInsider.

In PLOS this week: epigenetic drug triggers anti-viral activity, viral diversity among individuals with HIV experiencing virological failure, and more.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.